257 related articles for article (PubMed ID: 24098451)
1. Fucosylated but not sialylated milk oligosaccharides diminish colon motor contractions.
Bienenstock J; Buck RH; Linke H; Forsythe P; Stanisz AM; Kunze WA
PLoS One; 2013; 8(10):e76236. PubMed ID: 24098451
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study.
Sprenger N; Lee LY; De Castro CA; Steenhout P; Thakkar SK
PLoS One; 2017; 12(2):e0171814. PubMed ID: 28182762
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of a novel α-L-fucosidase from Pedobacter sp. and its application in synthesis of 3'-fucosyllactose and 2'-fucosyllactose.
Shi R; Ma J; Yan Q; Yang S; Fan Z; Jiang Z
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5813-5826. PubMed ID: 32388762
[TBL] [Abstract][Full Text] [Related]
4. Formula supplementation with human and bovine milk oligosaccharides modulates blood IgG and T-helper cell populations, and
Monaco MH; Wang M; Hauser J; Yan J; Dilger RN; Donovan SM
Front Immunol; 2023; 14():1327853. PubMed ID: 38179055
[TBL] [Abstract][Full Text] [Related]
5. HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related
Bajic D; Wiens F; Wintergerst E; Deyaert S; Baudot A; Van den Abbeele P
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049541
[TBL] [Abstract][Full Text] [Related]
6. The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation.
Perdijk O; van Neerven RJJ; van den Brink E; Savelkoul HFJ; Brugman S
PLoS One; 2018; 13(7):e0200356. PubMed ID: 29990329
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of fucosyllactose using α-L-fucosidases GH29 from infant gut microbial metagenome.
Moya-Gonzálvez EM; Zeuner B; Thorhallsson AT; Holck J; Palomino-Schätzlein M; Rodríguez-Díaz J; Meyer AS; Yebra MJ
Appl Microbiol Biotechnol; 2024 May; 108(1):338. PubMed ID: 38771321
[TBL] [Abstract][Full Text] [Related]
8. Early development of infant gut microbiota in relation to breastfeeding and human milk oligosaccharides.
Chichlowski M; van Diepen JA; Prodan A; Olga L; Ong KK; Kortman GAM; Dunger DB; Gross G
Front Nutr; 2023; 10():1003032. PubMed ID: 36969811
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
[TBL] [Abstract][Full Text] [Related]
10. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
[TBL] [Abstract][Full Text] [Related]
11. Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function.
Šuligoj T; Vigsnæs LK; Abbeele PVD; Apostolou A; Karalis K; Savva GM; McConnell B; Juge N
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32933181
[TBL] [Abstract][Full Text] [Related]
12. Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells.
Laucirica DR; Triantis V; Schoemaker R; Estes MK; Ramani S
J Nutr; 2017 Sep; 147(9):1709-1714. PubMed ID: 28637685
[No Abstract] [Full Text] [Related]
13. Human milk oligosaccharides differentially support gut barrier integrity and enhance Th1 and Th17 cell effector responses
Boll EJ; Lopez DV; Terne M; Hessing S; Parschat K; Jensen SR
Front Immunol; 2024; 15():1359499. PubMed ID: 38510254
[TBL] [Abstract][Full Text] [Related]
14. In vitro fermentation characteristics of select nondigestible oligosaccharides by infant fecal inocula.
Vester Boler BM; Rossoni Serao MC; Faber TA; Bauer LL; Chow J; Murphy MR; Fahey GC
J Agric Food Chem; 2013 Mar; 61(9):2109-19. PubMed ID: 23379900
[TBL] [Abstract][Full Text] [Related]
15. HMOs Impact the Gut Microbiome of Children and Adults Starting from Low Predicted Daily Doses.
Bajic D; Wiens F; Wintergerst E; Deyaert S; Baudot A; Abbeele PVD
Metabolites; 2024 Apr; 14(4):. PubMed ID: 38668367
[TBL] [Abstract][Full Text] [Related]
16. Activation of the G-protein coupled receptor GPR35 by human milk oligosaccharides through different pathways.
Foata F; Sprenger N; Rochat F; Damak S
Sci Rep; 2020 Sep; 10(1):16117. PubMed ID: 32999316
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Human Milk Oligosaccharide Supplementation During Critical Periods of Development on the Mesolimbic Dopamine System.
Noye Tuplin EW; Chleilat F; Alukic E; Reimer RA
Neuroscience; 2021 Apr; 459():166-178. PubMed ID: 33588004
[TBL] [Abstract][Full Text] [Related]
18. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
[TBL] [Abstract][Full Text] [Related]
19. Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity.
Donovan SM; Comstock SS
Ann Nutr Metab; 2016; 69 Suppl 2(Suppl 2):42-51. PubMed ID: 28103609
[TBL] [Abstract][Full Text] [Related]
20. Specific Human Milk Oligosaccharides Differentially Promote Th1 and Regulatory Responses in a CpG-Activated Epithelial/Immune Cell Coculture.
Zuurveld M; Ayechu-Muruzabal V; Folkerts G; Garssen J; Van't Land B; Willemsen LEM
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
